- Home
- LNTH vs NOVT Comparison
LNTH vs NOVT Comparison
Compare LNTH & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- NOVT
- Stock Information
- Founded
- LNTH 1956
- NOVT 1968
- Country
- LNTH United States
- NOVT United States
- Employees
- LNTH N/A
- NOVT N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NOVT Industrial Machinery/Components
- Sector
- LNTH Health Care
- NOVT Miscellaneous
- Exchange
- LNTH Nasdaq
- NOVT Nasdaq
- Market Cap
- LNTH 5.7B
- NOVT 4.8B
- IPO Year
- LNTH 2015
- NOVT N/A
- Fundamental
- Price
- LNTH $70.57
- NOVT $120.10
- Analyst Decision
- LNTH Strong Buy
- NOVT Hold
- Analyst Count
- LNTH 5
- NOVT 1
- Target Price
- LNTH $131.20
- NOVT $160.00
- AVG Volume (30 Days)
- LNTH 1.1M
- NOVT 250.6K
- Earning Date
- LNTH 08-06-2025
- NOVT 08-05-2025
- Dividend Yield
- LNTH N/A
- NOVT N/A
- EPS Growth
- LNTH N/A
- NOVT 1.57
- EPS
- LNTH 3.53
- NOVT 1.95
- Revenue
- LNTH $1,536,699,000.00
- NOVT $951,695,000.00
- Revenue This Year
- LNTH $4.57
- NOVT $5.66
- Revenue Next Year
- LNTH $9.41
- NOVT $7.78
- P/E Ratio
- LNTH $19.99
- NOVT $61.59
- Revenue Growth
- LNTH 12.53
- NOVT 6.52
- 52 Week Low
- LNTH $69.12
- NOVT $98.76
- 52 Week High
- LNTH $118.21
- NOVT $186.75
- Technical
- Relative Strength Index (RSI)
- LNTH 35.55
- NOVT 38.10
- Support Level
- LNTH $70.40
- NOVT $121.79
- Resistance Level
- LNTH $73.52
- NOVT $124.92
- Average True Range (ATR)
- LNTH 2.48
- NOVT 3.44
- MACD
- LNTH -0.27
- NOVT -0.63
- Stochastic Oscillator
- LNTH 10.21
- NOVT 21.59
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.